FDA Drug Safety Communication: Safety Review Update of Abacavir and Possible Increased Risk of Heart Attack - Drugs.com MedNews
Links shared publicly online about this topic.
- 469total visits
FDA Drug Safety Communication: Safety Review Update of Abacavir and Possible Increased Risk of Heart Attack - Drugs.com MedNews
Safety Announcement Additional Information for Patients Additional Information for Healthcare Professionals Data Summary Safety Announcement 03-01-2011 The U.S.
View full resource at drugs.com
Tags: Heart, Heart Attack, HIV Medication, Drug, FDA, Ziagen, Safety
Most Recently Shared on March 2, 2011 at 1:14 pm By:
FDA Drug Safety Communication: Safety Review Update of Abacavir and Possible Increased Risk of Heart Attac... http://bit.ly/fTwPDX #drug
FDA Drug Safety Communication: Safety Review update of Abacavir and possible increased risk of heart attack
fda.gov — “The U.S. Food and Drug Administration (FDA) is updating the public about its ongoing safety review of abacavir and a possible increased risk of heart attack.” View full resource at fda.gov
Most Recently Shared on March 1, 2011 at 7:08 pm By:
Lisa Morris Bonsall Nurse and Advanced Practice Nurse
FDA - Safety Review update of Abacavir and possible increased risk of heart attack http://bit.ly/ekjvVV
Advertisement
